562
Participants
Start Date
February 29, 2004
Primary Completion Date
November 30, 2006
TPV500mg/RTV200mgBID
TPV500mg/RTV100mgBID
LPV400mg/RTV100mgBID
Boehringer Ingelheim Investigational Site, BsAs
Fundacion Huesped, Buenos Aires
Hospital de Agudos Teodoro Alvarez, Buenos Aires
Hospital Posadas, Haedo
Boehringer Ingelheim Investigational Site, Darlinghurst
St Vincents Hospital;, Darlinghurst
Boehringer Ingelheim Investigational Site, Liverpool
Boehringer Ingelheim Investigational Site, Surry Hills
Boehringer Ingelheim Investigational Site, Carlton
Alfred Hospital, Melbourne
Boehringer Ingelheim Investigational Site, South Yarra
Unidade de Pesquisa Clínica (UPC) - AIDS, Campinas - Sp
Boehringer Ingelheim Investigational Site, Curitiba - PR
Boehringer Ingelheim Investigational Site, Manguinhos - Rio de Janeiro - RJ
Instituto de Crianca / Hospital das Clínicas-FMUSP, Mooca / São Paulo
Hospital Geral de Nova Iguaçu - Ministério da Saúde, Nova Iguaçu - RJ
Universidade Federal do Rio de Janeiro, Rio de Janeiro - RJ
Hospital Dia, Sacoma - São Paulo
Universidade Federal da Bahia-Unidade Docente Assistencial d, Salvador - BA
Boehringer Ingelheim Investigational Site, Santos - Sp
Hospital do Servidor Público Estadual de São Paulo, São Paulo - Sp
I.I. Emilio Ribas - Moléstias Infecciosas, São Paulo - SP
Instituto de Infectologia Emílio Ribas, São Paulo - SP
UNIFESP/ Hospital São Paulo- Univers. Federal de São Paulo, São Paulo - Sp
Centro de Referência e Treinamento - DST/AIDS, Vila Mariana - Sao Paulo
Downtown Infectious Diseases Clinic, Vancouver
Boehringer Ingelheim Investigational Site, Winnipeg
McMaster University Medical Centre, Hamilton
The Ottawa Hospital Riverside Campus, Ottawa
Canadian Immunodeficiency Research Collaborative Inc., Toronto
St. Michael's Hospital, Toronto
Sunnybrook & Woman's College Health Science Centre, Toronto
Toronto General Hospital, Toronto
Boehringer Ingelheim Investigational Site, Whitby
Montreal General Hospital - McGill University Health Centre, Monteal
Boehringer Ingelheim Investigational Site, Montreal
Montreal Chest Institute, McGill University Health Centre, Montreal
Boehringer Ingelheim Investigational Site, Bogotá
Hôpital Jean Verdier, Bondy
Hôpital Bocage, Dijon
Hôpital Albert Michallon, La Tronche
Hop Hôtel Dieu, Lyon
Hôpital Gui de Chauliac, Montpellier
Hôpital Saint Antoine, Paris
Hôpital Bellevue, Saint-Etienne
Epimed GmbH, Berlin
Klinikum der Ruhr-Universität Bochum, Bochum
Universitätsklinik Köln, Cologne
Boehringer Ingelheim Investigational Site, Düsseldorf
Universitätsklinikum Düsseldorf, Düsseldorf
Universitätsklinikum Essen, Essen
ifi Studien und Projekte GbR, Hamburg
Medizinische Poliklinik, München
Hospital de Especialidades no. 25, Col. Morelos, Monterrey, N. L.
Hospital Juan I. Menchaca IMSS, Col. Villaseñor, Guadalajara, Jal.
Hospital Lopez Mateos, México
Centre for AIDS Diagnostics and Therapy, Chorzów
Medical Academy of Szczecin, Szczecin
Hospital for Infectious Diseases, Warsaw
Department of Infectious Diseases, Wroclaw
Matei Bals Institute of Infectious Diseases, Bucharest
Victor Babes Clincial Hospital, Bucharest
Russian Federal Scientific, Moscow
City Hospital St Petersburg, Saint Petersburg
Boehringer Ingelheim Investigational Site, Badalona
Boehringer Ingelheim Investigational Site, Barcelona
Hospital Clínico y Provincial, Barcelona
Ciutat Sanitaria Universitaria de Bellvitge, Hospitalet de Llobregat (Barcelona)
Boehringer Ingelheim Investigational Site, Madrid
Hospital 12 de octubre, Madrid
Hospital Ramón y Cajal, Madrid
Boehringer Ingelheim Investigational Site, Málaga
Boehringer Ingelheim Investigational Site, Santa Cruz de Tenerife
Hospital Universitario Vírgen del Rocío, Seville
Hospital Mútua de Terrasa, Terrassa
Ramathibodhi Hospital, Bangkok
King Chulalonkorn Hospital, Pathumwan, Bangkok
Princess Margaret Hospital, Nassau
Boehringer Ingelheim Investigational Site, Edinburgh
North Middlesex Hospital, London
Royal Free Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY